J, T., A, G., M, M., C, H., A, T., R, M., . . . I, H. (2026). Hepatitis C therapy with pangenotypic direct-acting antivirals: Drug-drug interactions in drug-using HCV patients and antipsychotic-treated HCV patients. Adicciones, 38(1), 25. https://doi.org/10.20882/adicciones.2296
Chicago Style (17th ed.) CitationJ, Turnes, García-Herola A, Méndez M, Hernández C, Trento A, Morillo-Verdugo R, Pascual F, and Hernández I. "Hepatitis C Therapy with Pangenotypic Direct-acting Antivirals: Drug-drug Interactions in Drug-using HCV Patients and Antipsychotic-treated HCV Patients." Adicciones 38, no. 1 (2026): 25. https://doi.org/10.20882/adicciones.2296.
MLA (9th ed.) CitationJ, Turnes, et al. "Hepatitis C Therapy with Pangenotypic Direct-acting Antivirals: Drug-drug Interactions in Drug-using HCV Patients and Antipsychotic-treated HCV Patients." Adicciones, vol. 38, no. 1, 2026, p. 25, https://doi.org/10.20882/adicciones.2296.